Actinium Pharmaceuticals
ATNM
#9343
Rank
โ‚ฌ43.78 M
Marketcap
1,40ย โ‚ฌ
Share price
5.76%
Change (1 day)
-64.44%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -โ‚ฌ43.39 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.08 Million. In 2023 the company made an earning of -โ‚ฌ49.58 Million a decrease over its 2022 earnings that were of -โ‚ฌ32.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ43.39 Million-12.5%
2023 -โ‚ฌ49.58 Million52.24%
2022 -โ‚ฌ32.57 Million36.61%
2021 -โ‚ฌ23.84 Million11.48%
2020 -โ‚ฌ21.39 Million1.46%
2019 -โ‚ฌ21.08 Million-7.37%
2018 -โ‚ฌ22.76 Million-11.46%
2017 -โ‚ฌ25.7 Million10.67%
2016 -โ‚ฌ23.23 Million15.7%
2015 -โ‚ฌ20.07 Million-14.86%
2014 -โ‚ฌ23.58 Million129.19%
2013 -โ‚ฌ10.29 Million-8.55%
2012 -โ‚ฌ11.25 Million
2010 โ‚ฌ0 M-152.15%
2009 -โ‚ฌ0.02 Million-39.8%
2008 -โ‚ฌ0.03 Million120.29%
2007 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ35.52 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ95.34 Million 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA